Funding Opportunity RFA-OD-22-023 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31.

Notice NOT-DE-23-003 from the NIH Guide for Grants and Contracts

Notice NOT-AI-23-004 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-110 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-OH-23-004 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to enhance the quality and complement the availability of health and safety training for mineworkers in the Western United States. As a result, the National Institute for Occupational Safety and Health (NIOSH) invites applications for cooperative agreements to support the development and implementation of training and education programs.

Funding Opportunity RFA-CA-23-013 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NCI R25 program is to support research and educational activities that enhance the diversity of the cancer biomedical workforce. We seek to do this by providing training navigation to support scholars from diverse backgrounds, including individuals from groups shown to be underrepresented in the cancer biomedical workforce. The TEAM program will pilot test the use of training champions (TCs) at minority serving institutions (MSIs) to support the development of educational activities and scientific career development programs to enhance the preparation, productivity and progress of scholars from diverse backgrounds, including those from underrepresented racial and ethnic groups, in the Notice of NIH's Interest in Diversity, NOT-OD-20-031. The career development levels of focus for this FOA will include predoctoral and postdoctoral fellows, and early-stage investigators (ESIs). TCs are defined as personnel located within the MSI who can assist potential applicants with their plans to apply, attain, or transition to an independent grant award. This RFA will leverage TCs to assist scholars in identifying funding opportunities, networking with appropriate NCI/NIH program directors, and locating resources for competitive application preparation. TCs will also provide additional training support, navigation, and resources to enhance the skills required to successfully identify, prepare, submit, and obtain grants and career development opportunities. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development and Mentoring Activities.

Funding Opportunity RFA-DA-23-036 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support projects that investigate the effects of addictive substances on developmental trajectories of molecularly-defined CNS cells and circuits. Emphasis is on carrying out systematic and highly granular quantitative characterizations of the impact of in utero and/or postnatal substance exposure on the numbers, spatial distribution and connectivity of molecularly-defined cells, across whole brains or within distributed circuits of clinical relevance. The ultimate goals of the program are to identify critical developmental windows and cellular mechanisms mediating the protracted developmental impact of addictive substances, and will inform clinical practice, by complementing the data from human longitudinal neuroimaging studies such as the ABCD study.?

Notice NOT-DA-24-005 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-020 from the NIH Guide for Grants and Contracts

Notice NOT-HG-23-012 from the NIH Guide for Grants and Contracts

Notice NOT-GM-23-017 from the NIH Guide for Grants and Contracts

Notice NOT-GM-23-021 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MD-22-010 from the NIH Guide for Grants and Contracts. The purpose of this program is to build capacity and research infrastructure and to facilitate minority health and health disparities research at eligible institutions, but not to directly support the research projects itself. NIMHD Research Endowment grants are made to create a permanent institutional endowment fund to support institutional resources and research capacity building.

Funding Opportunity RFA-NS-22-069 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is designed to support integrated efforts of three or more (up to six) PDs/PIs to pursue bold, impactful, and challenging research in basic and clinical pain domains to understand the biology of specific human pain conditions as well as pain associated with diverse diseases/disorders, including mechanistic underpinning of heterogeneity and stratification of patients with specific pain conditions and co-morbidities. The research approach should be interdisciplinary in nature, and the research teams are expected to establish a common goal that requires collaboration, synergy, and managed team interactions. Proposed research should not represent a collection of individual efforts or parallel projects. Proposed research should support a cohesive, single, well-integrated research plan with a singular focus, one set of aims, and a budget without subprojects. Teams must leverage appropriate multi-disciplinary expertise to develop new principles and methods for experimentation, analysis, and interpretation. Teams are encouraged to consider transformative objectives with defined 5-year outcomes that will produce major advances in the understanding of human pain conditions and are likely to improve strategies for effective managementof human pain.

Notice NOT-AG-22-045 from the NIH Guide for Grants and Contracts

Notice NOT-ES-23-001 from the NIH Guide for Grants and Contracts

Notice NOT-DA-24-004 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-24-004 from the NIH Guide for Grants and Contracts. The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Funding Opportunity RFA-DA-24-003 from the NIH Guide for Grants and Contracts. The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Notice NOT-DA-23-012 from the NIH Guide for Grants and Contracts